IP Library Granted Patent US 7,566,697
Granted Patent B2
US 7,566,697 · App. 10/517,392 · Granted Jul 28, 2009

Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,566,697
App. No.
10/517,392
Granted
Jul 28, 2009
Kind
B2
Abstract

The present invention provides methods of assembling oligopeptides or polypeptides in a native chemical ligation reaction that eliminates the formation of unwanted side products resulting from the presence of an unprotected acidic C-terminal oligopeptide thioester. An important aspect of the present invention is providing side chain protected acidic C-terminal oligopeptide thioesters. The present invention is useful in methods for chemical synthesis of oligopeptides, polypeptides and proteins and improves the efficiency of native chemical ligation reactions, particularly where aspartyl or glutamyl peptide fragments are used to assemble an oligopeptide, polypeptide or protein product.

Claims (8)

1. A method of chemically ligating two oligopeptides, wherein a first oligopeptide thioester having an acidic C-terminal amino acid, said acidic C-terminal amino acid having a thioester moiety, a side chain, and a side chain protecting group selected from the group consisting of: 9-fluorenylmethyl ester, (phenylsulfonyl)ethyl ester, 2,2,2-trichloroethyl ester, and a phenacyl ester, such that said side chain protecting group substantially prevents rearrangements between atoms of said side chain and atoms of said thioester moiety, is contacted with a second oligopeptide having an N-terminal amino acid under chemical ligation conditions such that said thioester moiety of said first oligopeptide thioester ligates to said N-terminus of said second oligopeptide to form an oligopeptide or polypeptide product.

2. The method of claim 1 wherein said side chain protecting group is a phenacyl ester having the formula:

—CH(R 13 )—CO—(C 6 H 4 )—R 14

wherein R 13 and R 14 are each electron-donating groups.

3. The method of claim 2 wherein R 13 and R 14 are each alkyl having from 1 to 3 carbon atoms.

4. The method of claim 3 wherein R 13 is methyl or ethyl.

5. The method of claim 1 wherein said N-terminal amino acid of said second oligopeptide is cysteine or an amino acid with a removable ethylthiol moiety.

6. The method of claim 1 wherein one of said first and second oligopeptide is attached to a solid support.

Assignments (5)
AMYLIN PHARMACEUTICALS, LLC ASSIGNS AN EQUAL AND UNDIVIDED ONE-HALF OF ITS ENTIRE RIGHT, TITLE AND INTEREST TO ASTRAZENECA PHARMACEUTICALS LP Recorded Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →
CHANGE OF NAME Recorded Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2007
From: GENEPROT, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 018916/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2007
From: GENEPROT, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 018916/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2005
From: BOTTI, PAOLO; VILLAIN, MATTEO; MANGANIELLO, SONIA; GAERTNER, HUBERT
To: GENEPROT, INC.
Reel/Frame 016879/0680 →